Safety and efficacy of neoadjuvant chemotherapy containing bevacizumab and interval debulking surgery for advanced epithelial ovarian cancer: A feasibility study
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25187
Abstract: The optimum treatment strategy for patients with unresectable advanced epithelial ovarian cancer is controversial. This study examined bevacizumab combined with neoadjuvant chemotherapy (NAC; paclitaxel plus carboplatin), followed by interval debulking surgery (IDS), for these patients. read more here.
Keywords: epithelial ovarian; advanced epithelial; ovarian cancer; neoadjuvant chemotherapy ... See more keywords
Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?
Sign Up to like & getrecommendations! Published in 2019 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2019.01.001
Abstract: OBJECTIVES To determine whether perioperative red blood cell transfusion (PRBCT) affects infection, thrombosis, or survival rates in epithelial ovarian cancer (EOC) patients undergoing neoadjuvant chemotherapy (NACT) and interval debulking surgery (IDS). METHODS Demographics, operative characteristics,… read more here.
Keywords: infection; transfusion; blood; infection thrombosis ... See more keywords
What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery?
Sign Up to like & getrecommendations! Published in 2021 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2021.06.025
Abstract: INTRODUCTION The benefit of a systematic lymphadenectomy is still debated in patients undergoing neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) in ovarian cancer (OC). The objective of this study was to evaluate the… read more here.
Keywords: year; ovarian cancer; cancer; lymph node ... See more keywords
Complete Laparoscopic Interval Debulking Surgery for Advanced Ovarian Cancer Achieves Similar Survival Outcomes to Open Approach: A Propensity-Matched Study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Investigative Surgery"
DOI: 10.1080/08941939.2022.2045396
Abstract: Abstract Background: To assess the laparoscopic interval debulking surgery (IDS) outcomes compared to laparotomy, by analyzing the overall survival (OS) and the progression free survival (PFS), as well as the intra- and post-operative morbidity. Methods:… read more here.
Keywords: interval debulking; surgery; ovarian cancer; debulking surgery ... See more keywords
Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2018-000200
Abstract: Objective The role of selective lymphadenectomy at the time of interval debulking surgery in patients with advanced ovarian cancer remains a topic of debate. This study aimed to evaluate the value of selective lymphadenectomy during… read more here.
Keywords: selective lymphadenectomy; lymphadenectomy; cancer; interval debulking ... See more keywords
Differences in Patterns of Recurrence Between Primary and Interval Debulking Surgery for Advanced Ovarian Cancer
Sign Up to like & getrecommendations! Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.15679
Abstract: Background/Aim: This study aimed to identify differences in the pattern and timing of recurrence in patients with advanced ovarian cancer undergoing primary (PDS) or interval debulking surgery after neoadjuvant chemotherapy (NACT). Patients and Methods: Data… read more here.
Keywords: debulking surgery; advanced ovarian; recurrence; interval debulking ... See more keywords
Does MIS Play a Role in the Treatment of Advanced Ovarian Cancer?
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14153579
Abstract: Simple Summary Minimally invasive surgery can be used for interval debulking after neoadjuvant chemotherapy in selected patients with ovarian cancer initial disease unresectable by laparotomy without compromising survival. The main benefit of minimally invasive surgery… read more here.
Keywords: surgical approach; interval debulking; ovarian cancer; minimally invasive ... See more keywords
Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Gynecologic Oncology"
DOI: 10.3802/jgo.2020.31.e86
Abstract: Background Two randomized phase III trials (EORTC55971 and CHORUS) showed similar progression-free and overall survival in primary or interval debulking surgery in ovarian cancer, however both studies had limitations with lower rate of complete resection… read more here.
Keywords: chemotherapy; surgery; ovarian cancer; cancer ... See more keywords